Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2005
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Good clinical practices (GCP) statement

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2005

Materials and methods

Type of sensitisation studied:
skin
Study type:
study with volunteers
Test guideline
Qualifier:
no guideline followed
Version / remarks:
Methods is in the attached report
Principles of method if other than guideline:
To determine the irritation and/or sensitization potential of the test article after repeated application under semi-occlusive patch test conditions to the skin of human subjects
GLP compliance:
not specified
Remarks:
GCP: Good Clinical Practices

Test material

Constituent 1
Reference substance name:
Fatty acids, C5-9, hexaesters with dipentaerythritol
EC Number:
267-021-7
EC Name:
Fatty acids, C5-9, hexaesters with dipentaerythritol
Cas Number:
67762-52-1
Molecular formula:
Not defined because UVCB
IUPAC Name:
Fatty acids, C5-9, hexaesters with dipentaerythritol
Test material form:
liquid: viscous
Details on test material:
Pale yellow liquid
Used as received

Method

Type of population:
general
Ethical approval:
confirmed and informed consent free of coercion received
Subjects:
- Number of subjects exposed: 55
- Sex: male and female
- Age: between 18 and 70
- Race: no data
- Demographic information: no data
- Other:
Each subject was assigned a permanent CRL identification number. All subject signed an Informed Consent Form in compliance with 21 CFR Part 50: "Protection of Human Subjects" and a HIPAA Authorization Form in compliance with 45 CFR Part 160 and 164. All subject completed a Subject Profile/Medical History Form provided by Clinical Research Laboratories, Inc. prior to the study (Subject Demographics - Appendix I). Subject who met the following criteria were impaneled:
- Male and Female panelists between the ages of 18 and 70
- Subjects who have completed a Panelist Profile/Medical History
- Subjects who are in general good health as determined by a Panelist Profile/Medical History
- Subjects who do not exhibit any skin diseases that might be confused with a skin reaction from the test material
- Subjets who agree to avoid exposure of the test sites to the sun and to refrain from visits to tanning salons during the course of the study
- Subject willing to sign an Informed Consent Form in conformance with 21 CFR Part 50: "Protection of Human Subjects"
- Females who are not pregnant or lactating
- Subjects who demonstrate dependability and intelligence in following directions
- Subjects who are not currently using systemic or topical corticosteroids, anti-inflammatory drugs or antihistamines
- Subjects who do not exhibit skin disorder, sunburn, scars, excessive tatoos, etc. in the test area
Clinical history:
The subjects did not exhibit any physical or dermatological condition that would have precluded application of the test article.
Route of administration:
dermal
Details on study design:
See test method in report attached

Results and discussion

Results of examinations:
This study was initiated with 56 subjects. One subject discontinued study participation for reasons unrelated to the test material. A total of 55 subjects completed the study.
Individual dermal scores recorded during the Induction and Challenge Phase appear in table 1 (report attached)
Based on the test population of 55 subjects and under the conditions of this study, the test material identified as Fatty acids, C5-9, hexaesters with dipentaerythritol did not demonstrate a potential for eliciting dermal irritation or sensitization

Applicant's summary and conclusion

Conclusions:
Based on the test population of 55 subjects and under the conditions of this study, the test material identified as Fatty acids, C5-9, hexaesters with dipentaerythritol did not demonstrate a potential for eliciting dermal irritation or sensitization
Executive summary:

To determine the irritation and/or sensitization potential of the test article after repeated application under occlusive patch test conditions to the skin of human subjects (non-exclusive panel).

Fifty-six (56) subjects, 6 males and 50 females, ranging in age from 18 to 67 years were impaneled for this test.

The 9 Repeated Insult (semi-occlusive) Patch Test (9 RIPT) was conducted.

Based on the test population of 55 subjects and under the conditions of this study, the test material identified as Fatty acids, C5-9, hexaesters with dipentaerythritol did not demonstrate a potential for eliciting dermal irritation or sensitization